OPID(SA)

BE 0884.084.724

Follow-up
Company information
Status
Active
Enterprise number
BE0884.084.724
VAT liability
Yes
Established
04-10-2006
Last balance sheet year
2023
Company size
Big 43,1 FTE
Full name
Omega Pharma Innovation & Development
Principal activity
Research and experimental development on biotechnology
Health barometer
Barometer background
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from OPID

2023202220212020
Profit/Loss
€ 9.744.433390%€ 1.988.571120%€ -9.851.35695%€ -186.073.005
Turnover
€ 55.237.93212%€ 49.139.15710%€ 44.673.2971%€ 44.057.699
Equity
€ 124.642.5271%€ 123.398.0932%€ 121.409.522-56%€ 274.825.457
Gross margin
€ 27.082.14317%€ 23.076.08140%€ 16.474.80511%€ 14.888.867
Employees
43,1-3%44,5-5%46,7-1%47

Publications in the Belgian Official Journal from OPID

Frequently asked questions

What is the VAT number of Omega Pharma Innovation & Development?
The VAT number of Omega Pharma Innovation & Development is BE0884084724.
When was Omega Pharma Innovation & Development founded?
Omega Pharma Innovation & Development was founded on 04-10-2006.
What is the address of Omega Pharma Innovation & Development?
The current registered office of Omega Pharma Innovation & Development is located at Gaston Crommenlaan 6/606, 9050 Gent.
When was the last time Omega Pharma Innovation & Development filed their annual financial statements?
The most recent financial statements of Omega Pharma Innovation & Development were filed on 31-05-2024. You can view them here.
How many employees does Omega Pharma Innovation & Development have?
There are 43,1 FTEs working at Omega Pharma Innovation & Development according to the staff figures in the most recent financial statements.
What is the annual turnover of Omega Pharma Innovation & Development?
At the time of its most recent financial statements, Omega Pharma Innovation & Development recorded a total turnover of €55,237,932.00.